The Combinostics cNeuro™ platform combines the company’s innovative AI technology with a holistic view of patient data (imaging biomarkers, demographic and clinical data, neuropsychology test results, and other biomarkers) to enable clinicians to make reliable, evidence-based diagnostic and management decisions for their patients with neurological disorders.
Location: Finland, West Finland, Tampere
Employees: 11-50
Phone: +46 73 069 90 57
Total raised: $4.3M
Founded date: 2014
Investors 2
| Date | Name | Website |
| - | NordicNinj... | nordicninj... |
| - | MassChalle... | masschalle... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 22.11.2019 | Series A | $4.3M | - |
Mentions in press and media 21
| Date | Title | Description |
| 07.04.2026 | Change of date for the Annual General Meeting in SyntheticMR AB (publ) | Change of date for the Annual General Meeting in SyntheticMR AB (publ) Tue, Apr 07, 2026 15:46 CET Report this content SyntheticMR AB (publ) has previously announced that the Annual General Meeting 2026 would be held on Tuesday, May 12, 202... |
| 06.02.2026 | Year-End report January – December 2025 | Year-End report January – December 2025 Fri, Feb 06, 2026 08:30 CET Report this content Fourth quarter in brief Net sales amounted to 18.0 million SEK (12.6), which means an increase in sales of 42 percent. Operating profit amounted to -5.3... |
| 22.01.2026 | SyntheticMR Secures Capital for Global AI Neurodiagnostics Expansion Amidst Strong Q4 Revenue Surge | SyntheticMR AB launches a SEK 32.8 million rights issue. Shareholders approved the capital raise. This funding fuels strategic growth. Preliminary Q4 2025 financials reveal a 43% revenue surge. The company leverages its Combinostics acquisi... |
| 19.01.2026 | SyntheticMR AB publishes financial guidance ahead of the forthcoming rights issue | SyntheticMR AB publishes financial guidance ahead of the forthcoming rights issue Mon, Jan 19, 2026 08:48 CET Report this content SyntheticMR AB (publ) (“SyntheticMR” or the “Company”) publishes financial guidance based on preliminary figur... |
| 16.01.2026 | Regulatory Approval for ARIA Monitoring Strengthens SyntheticMR’s Position with a Broader Neuroimaging Offering | Regulatory Approval for ARIA Monitoring Strengthens SyntheticMR’s Position with a Broader Neuroimaging Offering Fri, Jan 16, 2026 09:15 CET Report this content SyntheticMR AB (publ), a global leader in quantitative MRI software, today annou... |
| 28.11.2025 | Interim report July – September 2025 | Interim report July – September 2025 Fri, Nov 28, 2025 08:00 CET Report this content Third quarter in brief Net sales amounted to 12.4 million SEK (13.3), which means a decrease in sales of 7 percent. Operating profit amounted to -25.1 mill... |
| 25.11.2025 | SyntheticMR AB (publ) postpones the interim report for the third quarter of 2025 | SyntheticMR AB (publ) postpones the interim report for the third quarter of 2025 Tue, Nov 25, 2025 19:07 CET Report this content The Board of Directors of SyntheticMR AB (publ) has decided to postpone the publication of the interim report f... |
| 22.11.2025 | Marcel Warntjes resigns from the Board of Directors of SyntheticMR AB (publ) | Marcel Warntjes resigns from the Board of Directors of SyntheticMR AB (publ) Sat, Nov 22, 2025 15:53 CET Report this content 22 November 2025 SyntheticMR AB (publ) announces today that Marcel Warntjes, at his own request, has decided to res... |
| 29.10.2025 | Nomination Committee appointed for the 2026 Annual General Meeting in SyntheticMR | Nomination Committee appointed for the 2026 Annual General Meeting in SyntheticMR Wed, Oct 29, 2025 08:50 CET Report this content The following shareholders have been identified as the three largest shareholders as of 2025-09-30 who are wil... |
| 01.09.2025 | Lena Åredal Assumes Role as CEO of SyntheticMR AB (publ) | Lena Åredal Assumes Role as CEO of SyntheticMR AB (publ) Mon, Sep 01, 2025 08:18 CET Report this content On June 13, the Board of Directors of SyntheticMR announced the appointment of Lena Åredal as the company’s new Chief Executive Officer... |
Show more